Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The Future of Biotechnologyㅡ MEDIPOST 1. MEDIPOST ?! "Care for Patients, Innovations from Research" Making better quality living within reach MEDIPOST is a leading stem cell biotechnology company focused on developing products to meet unmet medical needs such as those related to regenerative or functional recovery of knee articular cartilage, the nervous system, the pulmonary system and hematopoietic transplantation engraftment areas. 1. HISTORY OF MEDIPOST (2000~2006) 1. HISTORY OF MEDIPOST (2007~2010) 1. HISTORY OF MEDIPOST (2011~) Contents Overview Cord blood bank 1. public cord blood bank 2. family cord blood bank Nutritional supplements Overview • Revolution in medical care • MEDIPOST is committed to providing cord blood(脐带血/ 제대혈) banking services an d innovative adult stem cell drugs. • Cord blood is the blood remaining in the n ewborn‘s umbilical cord after birth, and it can only be collected at the time of birth. 2-1. PUBLIC CORD BLOOD BANK • Public Cord Blood Bank provides a valuable r esource to anyone who may need to undergo a Hematopoietic Stem Cell Transplantation (H SCT) as a result of blood-related diseases. • MEDIPOST Public Cord Blood Bank stores over 9,000 units and has provided over 40 0 units of cord blood for successful hemat opoietic stem cell transplantation (HSCT) cases. 2-2. FAMILY CORD BLOOD BANK • MEDIPOST's Family Cord Blood Bank - Cel lTree® provides a service for storing your newborn's cord blood exclusively for your family's use. • Using the cord blood from a family membe r can increase the efficacy of hematopoieti c stem cell transplantation (HSCT) as muc h as two-fold compared to using the cord blood from an unrelated donor. 2-2. FAMILY CORD BLOOD BANK • MEDIPOST's Family Cord Blood Bank - Cel lTree® stores over 134,000 units of cord bl ood 2.3- Nutritional supplements • MEDIPOST provides quality vitamins and nutritional supplements for the benefits of t he pregnant, kids and the elderly. Testing Human (Phase I, II, III, IV…) Investigational New Drug application Testing Animal Biologic License Application 2.4 - Adult Stem Cell Drugs CARTISTEM® • Stem cell drug for the treatment of Traumatic and Degenerative Osteoarthritis (OA) under license from the Korea Food and Drug Administration (KFDA). • Basically stem cells are used from human Umbilical Cord • Not provoked an immune response when administered • Has also received US FDA clearance to conduct Phase NEUROSTEM® Blood. Neuro-degenerative disorders. • Such Use as theAlzheimer's stem cell obtained from another individual disease (AD) Currently at clinical trial phase I. (a term known as 'allogeneic'). In Phase III, recovered cartilage of 65 years man. PNEUMOSTEM® PROMOSTEM® into another individual due to use of MSCs.Aims to promote early Pulmonary(Lung) disorders. Such as bronchopulmonary engraftment of donor HSCs • Off-the-Shelf, now available in Korea through the sales dysplasia (BPD). following transplantation and and distribution by Dong-A Pharmaceuticals Co., Ltd. the success rate of HSCT. Currently at clinical trial phase I. improve I/IIa clinical trials in the US. 2.5 - Stem cells known as Mesenchymal Stem Cells (MSCs) Privilege of Child hUCB-MSCs Have a special 'immune-privileged' characteristic. From an unrelated donor can be used to treat conditions of any patient. Without concerns of immune-rejection. Reference Terms http://terms.naver.com/entry.nhn?docId=429717 Pictures http://cafe.naver.com/sarangbang07.cafe?iframe_url=/ArticleRead.nhn%3F articleid=1214& http://blog.naver.com/genetic2002?Redirect=Log&logNo=30119466772 http://cafe.naver.com/doubiepolaris.cafe?iframe_url=/ArticleRead.nhn%3Fa rticleid=173& http://terms.naver.com/entry.nhn?docId=429717 http://cafe.naver.com/stockschart.cafe?iframe_url=/ArticleRead.nhn%3Farti cleid=34123& http://blog.naver.com/ws88kr?Redirect=Log&logNo=120105494109 http://www.xpand-biotech.com/technology_bioreactor.htm fasdfasdf 3.1 - hUCB-MSC 3.2 - Stem Cell Manufacturing 3.3 - Stem Cell Efficacy 4.1 - SUBJECT • Human cord blood-derived Mesenchymal Stem Cells (hUCB-MSCs) 4.2 - CORD BLOOD? • the blood in umbilical cord • many hematopoietic stem cells 4.3 - For what? • Treatment - Osteoarthritis Stroke Alzheimer’s disease Bronchopulmonary dysplasia(BPD) • Technical development - Improving efficacy of stem cell transplantation